John A. DeFord, Ph.D. Joins NuVasive Board
Elizabeth Hofheinz, M.P.H., M.Ed. • Thu, March 8th, 2018
John A. DeFord, Ph.D. now has a seat on the NuVasive, Inc. board of directors. Dr. DeFord is 25-year veteran of the medical device industry.
"We are pleased to welcome John to the NuVasive Board," said Gregory T. Lucier, chairman and chief executive officer of NuVasive, Inc.
"We expect John's experience driving innovative products and technology programs at other large medical device companies will help inform our own strategic direction as we quicken the tempo of our product launches and expand our efforts toward software development and a focus on systematizing spine surgery."
“Prior to his 13-year tenure at C.R. Bard, Dr. DeFord held various executive positions including president and chief executive officer with Cook Incorporated, now a multi-billion dollar privately held medical device manufacturer and served as managing director at Early Stage Partners LP, a venture capital firm focused on advanced materials, medical/biotechnology and information technology companies.”
Asked about his experience, Dr. DeFord told OTW, “I have more than 25 years of technology leadership experience in the medical device and biotechnology space. As Senior Vice President, Science, Technology and Clinical Affairs at C.R. Bard for the last 10 years, I led the company’s R&D efforts to develop groundbreaking medical devices and therapies.”
“I helped design products to save lives, help reduce costs and simplify procedures. I am excited about bringing this experience to the NuVasive board room and helping drive NuVasive’s vision to improve the lives of patients who suffer from debilitating back, neck or leg pain by creating cutting-edge products and procedures that revolutionize spine surgery.”
“I plan to spend some time learning more about the spine industry and gaining a deeper understanding of NuVasive’s innovative products and services.”
“While I have some prior spine industry experience, the spine industry is pretty dynamic—particularly as companies like NuVasive have advanced spine care with new technologies to proceduralize spine surgery. I am looking forward to working with the rest of the board and the leadership team to help NuVasive deliver impactful spine solutions and systems that truly change lives.